June 5, 2020 / 3:13 PM / a month ago

BRIEF-Luye Pharma Group Says Its Drug Rivastigmine Transdermal Patch Approved By Nmpa For Marketing

June 5 (Reuters) - Luye Pharma Group Ltd:

* LUYE PHARMA GROUP SAYS ITS DRUG RIVASTIGMINE TRANSDERMAL PATCH APPROVED BY NMPA FOR MARKETING Source text bit.ly/2Y8yGDK Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below